Biosynthesis and Immunological Evaluation of a Dual-Antigen Nanoconjugate Vaccine against Brucella melitensis

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Engineering

• Publication date

  2023-05-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.eng.2023.04.007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models

  2022cited by this paper
• Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA) administered by parenteral or mucosal routes against Brucella ovis in BALB/c mice.

  2022cited by this paper
• A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes

  2022cited by this paper
• Construction of Orthogonal Modular Proteinaceous Nanovaccine Delivery Vectors Based on mSA-Biotin Binding

  2022cited by this paper
• Evaluation of Brucellosis Vaccines: A Comprehensive Review

  2022cited by this paper
• Emerging concepts in the science of vaccine adjuvants

  2021cited by this paper
• Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice

  2021cited by this paper
• Nanovaccine: an emerging strategy

  2021cited by this paper
• Design of a new multi-epitope vaccine against Brucella based on T and B cell epitopes using bioinformatics methods

  2021cited by this paper
• Production of a Promising Biosynthetic Self‐Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host

  2021cited by this paper
• Prophylactic vaccine delivery systems against epidemic infectious diseases

  2021cited by this paper
• Broadly Protective CD8+ T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine

  2021cited by this paper
• Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection

  2021cited by this paper
• Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors

  2020cited by this paper
• Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.

  2020cited by this paper
• Bioinformatics analysis of candidate proteins Omp2b, P39 and BLS for Brucella multivalent epitope vaccines.

  2020cited by this paper
• Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production

  2020cited by this paper
• Application of an O-Linked Glycosylation System in Yersinia enterocolitica Serotype O:9 to Generate a New Candidate Vaccine against Brucella abortus

  2020cited by this paper
• Glycoconjugate vaccines: some observations on carrier and production methods.

  2019cited by this paper
• Infection by Brucella melitensis or Brucella papionis modifies essential physiological functions of human trophoblasts

  2019cited by this paper
• Novel multi‐component vaccine approaches for Burkholderia pseudomallei

  2019cited by this paper
• Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis?

  2019cited by this paper
• Immune Response to Mucosal Brucella Infection

  2019cited by this paper
• In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice

  2019cited by this paper
• Glycoconjugate vaccines: Principles and mechanisms

  2018cited by this paper
• Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo

  2018cited by this paper
• New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue

  2018cited by this paper
• Harnessing Nanoparticles for Immunomodulation and Vaccines

  2017cited by this paper
• Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans

  2017cited by this paper
• Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.

  2017cited by this paper
• Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo

  2017cited by this paper
• Biosynthesis of Conjugate Vaccines Using an O-Linked Glycosylation System

  2016cited by this paper
• Status of vaccine research and development for Shigella.

  2016cited by this paper
• Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches

  2016cited by this paper
• The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice

  2016cited by this paper
• The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis

  2016cited by this paper
• Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization

  2016cited by this paper
• A novel recombinant multi-epitope protein against Brucella melitensis infection.

  2016cited by this paper
• Multigene Editing in the Escherichia coli Genome via the CRISPR-Cas9 System

  2015cited by this paper
• Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization

  2015cited by this paper
• Peptide-based synthetic vaccines

  2015cited by this paper
• Brucella melitensis 16MΔTcfSR as a potential live vaccine allows for the differentiation between natural and vaccinated infection.

  2015cited by this paper
• In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate

  2014cited by this paper
• Molecular recognition of Brucella A and M antigens dissected by synthetic oligosaccharide glycoconjugates leads to a disaccharide diagnostic for brucellosis.

  2014cited by this paper
• A History of the Development of Brucella Vaccines

  2013cited by this paper
• Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis

  2013cited by this paper
• Economics of brucellosis impact and control in low-income countries.

  2013cited by this paper
• Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses

  2012cited by this paper
• Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against Brucella abortus.

  2011cited by this paper
• Emerging Vaccine Informatics

  2011cited by this paper
• Whole Genome Sequences of Four Brucella Strains

  2011cited by this paper
• Confronting the barriers to develop novel vaccines against brucellosis

  2011cited by this paper
• Brucellosis: Review on the Recent Trends in Pathogenicity and Laboratory Diagnosis

  2010cited by this paper
• A DNA Vaccine Prime Followed by a Liposome-Encapsulated Protein Boost Confers Enhanced Mucosal Immune Responses and Protection1

  2008cited by this paper
• A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.

  2007cited by this paper
• Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen

  2005cited by this paper
• Interactions between Brucella melitensis and Human Phagocytes: Bacterial Surface O-Polysaccharide Inhibits Phagocytosis, Bacterial Killing, and Subsequent Host Cell Apoptosis

  2003cited by this paper
• Epidemiology and control of brucellosis in China.

  2002cited by this paper
• Effects of Opsonization and Gamma Interferon on Growth of Brucella melitensis 16M in Mouse Peritoneal Macrophages In Vitro

  2000cited by this paper

• Advances in bacterial glycoprotein engineering: A critical review of current technologies, emerging challenges, and future directions.

  2025cites this paper
• Rapid detection assays for Bacillus anthracis, Yersinia pestis, and Brucella spp. via triplex-recombinase polymerase amplification

  2025cites this paper
• Screening and characterization of nucleic acid aptamers targeting Brucella surface antigens: identification and analysis of their corresponding binding sites

  2025cites this paper
• Micro- and nanoformulations of antibiotics against Brucella.

  2023cites this paper
• One-step preparation of a self-assembled bioconjugate nanovaccine against Brucella

  2023cites this paper